Download the full case study to see how real-time patient identification reshaped trial enrollment and delivered immediate results.
For over a year, a major Wisconsin-based IDN had an open prostate cancer trial—but no patients enrolled. The problem wasn’t a lack of eligible patients, but a manual, reactive process that left too many slipping through the cracks.
That changed when the team activated the OncoLens Clinical Trial Patient ID Report. In their very first review, they identified five new patients—three not yet presented at tumor board and two who never would have been considered at all. Within one week, the site enrolled its first patient on the trial, a milestone that validated their entire recruitment strategy.
Over the next 10 weeks, the report uncovered 30+ additional eligible patients across facilities, turning chance encounters into a scalable, proactive approach to clinical trial matching.
Latest
